Stock listing
TWSE:6919 Caliway Biopharmaceuticals Co Ltd (康霈*) 股價
Home listing (TWSE) of Caliway Biopharmaceuticals Co Ltd
Follow Caliway Biopharmaceuticals Co Ltd into a list and get an email when it puts out news.
Share price · TWSE:6919
$76.00 TWD +0.80 (+1.1%)
Close on Oct 21, 2026
- Day range
- $75.50 – $77.30 TWDOct 21, 2026
- Volume
- 2.00M sharesOct 21, 2026
- Market cap
- $118.3B TWDAt the close on Oct 21, 2026 · price × 1.56B shares outstanding
- 52-week range
- $74.80 – $188.00 TWDLowest and highest trades, Oct 22, 2025 – Oct 21, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TWSE:6919 · Home | $76.00 TWD | +0.80 (+1.1%) | 1,999,390 | $76.30 | $77.30 | $75.50 | $75.20 | Close on Oct 21, 2026 |
Daily closes
Last 3 months, Jul 21, 2026 – Oct 21, 2026 · TWSE:6919 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $76.00 | +0.80 | +1.1% | $76.30 | $77.30 | $75.50 | 1,999,390 | |
| $75.20 | -0.70 | -0.9% | $75.00 | $76.30 | $74.90 | 2,468,897 | |
| $75.90 | -1.00 | -1.3% | $76.80 | $76.80 | $74.80 | 2,471,006 | |
| $76.90 | +1.60 | +2.1% | $75.90 | $77.80 | $75.70 | 2,118,878 | |
| $75.30 | -3.00 | -3.8% | $78.30 | $78.30 | $75.10 | 3,540,166 | |
| $78.30 | +1.80 | +2.4% | $77.90 | $78.90 | $77.40 | 2,932,007 | |
| $76.50 | -0.70 | -0.9% | $76.50 | $78.00 | $75.10 | 4,398,813 | |
| $77.20 | -0.30 | -0.4% | $77.50 | $78.20 | $77.00 | 2,229,082 | |
| $77.50 | -0.60 | -0.8% | $78.10 | $79.10 | $77.50 | 2,950,946 | |
| $78.10 | -0.40 | -0.5% | $79.00 | $79.10 | $78.10 | 2,101,543 | |
| $78.50 | -0.30 | -0.4% | $79.10 | $79.20 | $78.10 | 2,563,797 | |
| $78.80 | -1.10 | -1.4% | $80.20 | $80.90 | $78.80 | 3,565,795 | |
| $79.90 | +0.80 | +1.0% | $79.10 | $80.40 | $78.50 | 3,635,766 | |
| $79.10 | +0.10 | +0.1% | $79.40 | $80.70 | $79.00 | 2,747,160 | |
| $79.00 | -0.50 | -0.6% | $81.00 | $81.40 | $79.00 | 5,214,982 | |
| $79.50 | -0.60 | -0.7% | $80.10 | $81.40 | $79.50 | 3,299,496 | |
| $80.10 | -0.50 | -0.6% | $80.90 | $82.00 | $79.80 | 3,951,337 | |
| $80.60 | -2.00 | -2.4% | $84.30 | $84.30 | $80.50 | 5,166,903 | |
| $82.60 | -0.50 | -0.6% | $88.00 | $89.50 | $82.20 | 8,245,884 | |
| $83.10 | -2.70 | -3.1% | $86.00 | $86.50 | $81.80 | 6,857,975 | |
| $85.80 | +2.90 | +3.5% | $83.90 | $86.00 | $83.30 | 6,464,359 | |
| $82.90 | +1.30 | +1.6% | $81.50 | $83.10 | $81.50 | 2,593,148 | |
| $81.60 | +1.70 | +2.1% | $80.40 | $83.50 | $79.70 | 4,166,800 | |
| $79.90 | +0.60 | +0.8% | $79.80 | $83.40 | $79.60 | 4,142,059 | |
| $79.30 | -0.20 | -0.3% | $79.70 | $80.80 | $78.90 | 2,862,127 | |
| $79.50 | -6.10 | -7.1% | $84.10 | $84.40 | $79.40 | 8,422,562 | |
| $85.60 | +3.20 | +3.9% | $82.10 | $86.30 | $77.30 | 13,731,804 | |
| $82.40 | +0.80 | +1.0% | $81.80 | $83.50 | $80.80 | 5,051,469 | |
| $81.60 | -3.60 | -4.2% | $85.30 | $86.20 | $81.60 | 7,796,917 | |
| $85.20 | -1.20 | -1.4% | $86.00 | $86.40 | $85.10 | 4,358,520 | |
| $86.40 | +1.90 | +2.2% | $83.50 | $87.20 | $81.60 | 8,669,515 | |
| $84.50 | -3.60 | -4.1% | $88.80 | $89.40 | $84.50 | 11,601,300 | |
| $88.10 | -3.10 | -3.4% | $90.00 | $91.50 | $88.10 | 9,532,965 | |
| $91.20 | -3.60 | -3.8% | $95.00 | $97.90 | $90.70 | 18,657,211 | |
| $94.80 | -4.80 | -4.8% | $99.90 | $103.50 | $94.80 | 84,080,003 | |
| $99.60 | -3.40 | -3.3% | $103.00 | $104.00 | $98.80 | 10,862,380 | |
| $103.00 | -3.00 | -2.8% | $106.00 | $108.00 | $103.00 | 5,855,542 | |
| $106.00 | +0.50 | +0.5% | $105.50 | $108.50 | $104.50 | 5,161,579 | |
| $105.50 | -5.00 | -4.5% | $110.50 | $112.00 | $105.00 | 5,938,730 | |
| $110.50 | -3.00 | -2.6% | $117.50 | $118.50 | $110.50 | 6,558,073 | |
| $113.50 | +4.50 | +4.1% | $108.50 | $118.00 | $107.50 | 11,255,400 | |
| $109.00 | +6.50 | +6.3% | $106.50 | $109.50 | $104.50 | 6,035,299 | |
| $102.50 | -2.00 | -1.9% | $104.00 | $105.50 | $102.50 | 2,105,421 | |
| $104.50 | +2.00 | +2.0% | $102.00 | $106.00 | $101.00 | 3,113,457 | |
| $102.50 | -1.50 | -1.4% | $106.00 | $106.00 | $102.00 | 3,004,529 | |
| $104.00 | 0.00 | 0.0% | $104.00 | $109.50 | $102.00 | 5,746,615 | |
| $104.00 | -6.50 | -5.9% | $109.00 | $109.00 | $103.00 | 8,620,998 | |
| $110.50 | +2.50 | +2.3% | $109.00 | $113.00 | $109.00 | 4,617,793 | |
| $108.00 | -3.00 | -2.7% | $110.00 | $112.50 | $108.00 | 4,082,269 | |
| $111.00 | +6.00 | +5.7% | $105.00 | $112.00 | $103.00 | 5,718,488 | |
| $105.00 | -2.50 | -2.3% | $107.50 | $108.00 | $105.00 | 2,996,870 | |
| $107.50 | -1.00 | -0.9% | $108.50 | $110.00 | $106.00 | 3,356,916 | |
| $108.50 | +0.50 | +0.5% | $109.00 | $111.00 | $107.00 | 4,434,456 | |
| $108.00 | -1.50 | -1.4% | $107.50 | $110.00 | $103.50 | 6,781,755 | |
| $109.50 | +6.50 | +6.3% | $102.00 | $110.00 | $102.00 | 7,516,308 | |
| $103.00 | 0.00 | 0.0% | $104.50 | $105.00 | $102.00 | 4,311,191 | |
| $103.00 | +1.00 | +1.0% | $102.00 | $103.00 | $99.00 | 5,196,661 | |
| $102.00 | -1.50 | -1.4% | $104.00 | $106.00 | $98.40 | 8,514,916 | |
| $103.50 | +1.50 | +1.5% | $100.50 | $104.50 | $99.10 | 5,644,014 | |
| $102.00 | +4.20 | +4.3% | $98.70 | $103.00 | $98.30 | 3,018,357 | |
| $97.80 | -2.70 | -2.7% | $98.50 | $101.50 | $97.50 | 3,349,768 | |
| $100.50 | -3.50 | -3.4% | $105.00 | $105.50 | $98.60 | 5,467,257 | |
| $104.00 | -1.00 | -1.0% | $105.50 | $106.00 | $104.00 | 2,708,605 | |
| $105.00 | -1.50 | -1.4% | $107.50 | $108.50 | $104.50 | 3,469,239 |
- Ticker
- TWSE:6919
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TWSE
- Currency
- TWD
What changed lately
Latest news
Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reduction
Sep 22, 2026
Closed $80.60 (-2.4%) on Sep 23, 2026
Caliway's CBL-514 Combination Therapy Cleared by U.S. FDA for Phase 2 Trial; Pivotal Phase 3 Trial SUPREME-01 Initiates Enrollment
Aug 25, 2026
Closed $106.00 (+0.5%) on Aug 26, 2026
Caliway Announces U.S. FDA IND Clearance for CBL-0302, Its Second Global Pivotal Phase 3 Study of CBL-514
May 22, 2026
Closed $104.00 (+2.5%) on May 22, 2026
Caliway Makes First ECO 2026 Oral Presentation on Preclinical Data of CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies, Attracting Strong Interest from International Experts and Global Pharmaceutical Companies for Its Systemic Metabolic Effects
May 19, 2026
Closed $104.00 (+9.6%) on May 19, 2026
Caliway's Fat Reduction Drug CBL-514 Phase 2 Clinical Results Accepted by ASJ. CBL-0204's Demonstrated Efficacy and Safety Gain Further Academic Recognition
Apr 13, 2026
Closed $107.00 (+2.4%) on Apr 14, 2026
Caliway Biopharmaceuticals Co Ltd on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 6 in the last 12 months · 16 in all · newest Sep 23, 2026 · oldest 2024
Where Caliway Biopharmaceuticals Co Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TWSE:6919 康霈* · Home listing · This page | TWSE | Taiwan | TWD |
| OTC:CLBPF | OTC | United States | USD |
Log in to ask 6ix AI your own questions about Caliway Biopharmaceuticals Co Ltd.